Tate & Lyle PLC

Public consensus   -   Last updated 29/04/21

Reporting currency: GBP
Reporting unit: Millions
 
NO. OF
FORECASTS
FY22
CONSENSUS
29/04/21
FY22
MEDIAN
FY22
MIN
FY22
MAX
Group Income Statement (£m)
Adjusted operating profit - Food & Beverage Solutions
Total Food & Beverage Solutions
11
189
184
182
205
Adjusted Operating Profit - SPLENDA® Sucralose
SPLENDA® Sucralose
11
49
48
45
54
Adjusted operating profit - Primary Products
Sweeteners and Starches
11
122
121
117
131
Commodities
11
15
15
10
22
Total Primary Products
11
137
138
131
146
Central costs
11
(50)
(50)
(56)
(47)
Adjusted operating profit
11
325
324
316
339
Adjusted profit before tax
11
325
325
310
338
Adjusted diluted EPS (p)
11
55.9
56.0
53.5
58.4
Dividend/Share (p)
11
30.7
30.5
29.6
32.6
$/£ assumption (average rate)
5
1.37
1.37
1.33
1.40
Group Cash Flow Statement (£m)
Adjusted Free cash flow (before exceptional cash flows)
10
246
249
198
270
Other cash flows in the year
Closing net debt
11
(297)
(287)
(612)
(201)

Disclaimer

Tate & Lyle PLC (“Tate & Lyle”) invites registered sell-side analysts that monitor Tate & Lyle’s stock to submit their forecasts to an external, web-based tool managed by Vuma Financial Limited (“Vuma”), a company independent of Tate & Lyle.

The web-based tool generates an aggregation of publicly available forecasts collated exclusively by Vuma, but only on the basis of information submitted by those analysts who choose to participate. The arithmetic average of the constituent analyst forecasts is known as “Consensus”. Vuma has no access to Tate & Lyle’s internal forecasts, budgets or any other information which is not publicly available.

Tate & Lyle has not commented on individual forecasts nor does it intend to do so in the future. Tate & Lyle assumes no obligation to update or revise such information and nothing in this analysis should be taken as a recommendation to buy or sell shares in Tate & Lyle or to take any other action or place any reliance on the analysis.

Consensus figures are provided for information only, and neither Tate & Lyle nor any of its subsidiary undertakings nor any director, officer or employee of Tate & Lyle or any of its subsidiary undertakings accepts any responsibility for the accuracy or completeness of forecasts used in this analysis and therefore shall have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in this analysis.